Abstract
I should admit, first of all, that the concept of a ‘fault’ in any system in essential hypertension worries me. Recognition of a fault implies that some individuals have that fault and others do not. This seems to be dangerously close to the heresy that held that hypertension was a discrete disease — a view so thoroughly refuted by Pickering [22]. Elevated blood pressure is like tallness, obesity, and an extrovert personality — a quantitative deviation from the norm. We are no more successful in finding a cause for high blood pressure in most hypertensive patients than we are in discovering a cause for a particular body stature or personality. In each case we are observing a constitutional quality that is determined multifactorially; we are particularly interested in hypertension because that quality is harmful to health and survival. If it were not, I strongly suspect that most of us would accept high blood pressure as part of a biological spectrum. Because hypertension has discrete consequences — strokes and heart attacks — we erroneously think of it as a discrete disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Barrett JD, Eggena P, Sambhi MP: Partial characterisation of aortic renin in the spontaneously hypertensive rat and its interrelationship with plasma renin, blood pressure and sodium balance. Clin Sci & Mol Med 55: 261–270, 1978
Bing J, Nielson K: Cause of the prolonged pressor action of renin in nephrectomised rats. Acta Path et Microbiol A 81: 247–253, 1973
Brunner HR, Wauters JP, McKinstry D, Waeber B, Turini G, Gavras H: Inappropriate renin secretion unmasked by captopril (SQ14225) in hypertension of chronic renal failure. Lancet ii: 704–707, 1978
Davis JO: The pathogenesis of chronic renovascular hypertension. Circ Res 40: 439–444, 1977
Devynck MA, Pernollet MG, MacDonald GJ, Matthews PG, Raisman RS, Meyer P: Alterations of adrenal and uterine angiotensin II receptors during variations of sodium intake and/or experimental hypertension. Clin Sci Mol Med 55: 4: 171s–174s, 1978
Doyle AE: Vascular reactivity in human hypertension. New Zealand Med J 67: 295–303, 1968
Dunn MJ, Tannen RL: Low-renin hypertension. Kidney Int 5: 317–325, 1974
Folkow B, Hallback M, Lundgren Y, Sivertsson R, Weiss L: Importance of adaptive changes in vascular design for establishment of primary hypertension studied in man and in spontaneously hypertensive rats. Cir Res (32)1: 2–16, 1973
Ganten D, Schelling P, Vecsei P, Ganten U: Iso-renin of extrarenal origin. Am J Med 60: 760–772, 1976
Gavras H, Brunner HR, Thurston H, Laragh JH: Reciprocation of renin dependency with sodium volume dependency in renal hypertension. Science 188: 1316–1317, 1975
Gavras H, Brunner HR, Vaughan ED, Laragh JH: Angiotensin-sodium interaction in blood pressure maintenance of renal hypertensive and normotensive rats. Science 180: 1369–1372, 1973
Gould AB, Skeggs LT, Kahn JR: Presence of renin activity in blood vessel walls. J Exp Med 119: 389–399, 1964
Gunther S, Gimbrone MA, Alexander RW: Regulation by angiotensin II of its receptors in resistance blood vessels. Nature 287: 230–232, 1980
Helmchen U, Kneissler U, Peters G: Disturbance of the control renin secretion in chronic one-kidney Goldblatt hypertension in the rat. Pflugers Arch 348: 197–204, 1974
Kuchel O, Fishman LM, Liddle GW, Michelakis A: Effect of diazoxide on plasma renin activity in hypertensive patients. Ann Intern Med 67: 791–799, 1967
Laragh JH: Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone properties. Am J Med 55: 261–274, 1973
Loudon M, Bing RF, Swales JD, Thurston H: Changes in blood pressure in relation to vascular and plasma renin after renin injection in rats. Clinical Science 63: 153s–156s, 1982
Marks ES, Russell GI, Thurston H, Bing RF, Swales JD: Responsiveness to pressor agents in experimental and steroid hypertension. Hypertension 4: 238–244, 1982
Mendlowitz M: Vascular reactivity in systemic arterial hypertension. Amer Heart J 85: 252–259, 1973
Pals DT, Masucci FD, Denning GS, Sipos F, Fessler DC: Role of the pressor action of angiotensin II in experimental hypertension. Circ Res 29: 673–681, 1971
Pettinger WA, Keeton K, Tanaka K: Radioimmunoassay and pharmacokinetics of saralasin in the rat and hypertensive patients. Clin Pharmacol Ther 17: 140–158, 1975
Pickering GW: High Blood Pressur. J and A Churchill, London, 1968
Reid IA: Is there a brain renin-angiotensin system? Circ Res 41: 147–153, 1977
Schalekamp MA, Beevers DG, Briggs JD, Brown JJ, Davies DL, Fraser R, Lebel M, Lever AF, Medina A, Morton JL, Robertson JIS, Tree M: Hypertension in chronic renal failure: an abnormal relation between sodium and the renin-angiotensin system. Am J Med 55: 379–390, 1973
Schwartz WB, Bennett W, Curelop S, Bartter FC: A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone. Am J Med 23: 529–542, 1957
Streeten DHP, Anderson GH, Freiberg JM, Dalakos TG: Use of an angiotensin II antagonist (saralasin) in the recognition of ‘angiotensinogenic’ hypertension. N Engl J Med 292: 657–662, 1975
Swales JD: On the inappropriate in hypertension research. Lancet ii: 702–704, 1977
Swales JD: Renin-angiotensin system in hypertension. Pharmac Ther 7: 173–201, 1979
Swales JD: Arterial wall or plasma renin in hypertension. Clin Sci 56: 293–298, 1979
Swales JD, Tange JD, Thurston H: Vascular angiotensin II receptors and sodium balance in rats. Role of kidneys and vascular renin activity. Circ Res 37: 96–100, 1975
Swales JD, Thurston H: Plasma renin and angiotensin II measurement in hypertensive and normotensive subjects: correlation of basal and stimulated states. J Clin Endocrinol Metab 45: 159–163, 1977
Swales JD, Thurston H, Querioz FP, Medina A: Sodium balance during the development of experimental hypertension. J Lab Clin Med 80: 539–547, 1972
Thurston H: Vascular angiotensin receptors and their role in blood pressure control. Am J Med 61: 768–778, 1976
Thurston H, Bing RF, Hurst B, Swales JD: Role of persistent vascular renin after bilateral nephrectomy in Goldblatt two-kidney hypertension. Clin Sci Mol Med 55: 4: 23s–26s, 1978
Thurston H, Bing RF, Pohl JEF, Swales JD: Renin sub-groups in essential hypertension: an analysis and critique. Quart J Med 47: 325–337, 1978
Thurston H, Laragh JH: Prior receptor occupancy as a determinant of the pressor activity of infused angiotensin II in the rat. Cir Res 36: 113–117, 1975
Thurston H, Swales JD, Bing RF, Hurst BC, Marks ES: Vascular renin like activity and blood pressure maintenance in the rat: studies of the effect of changes in sodium balance, hypertension and nephrectomy. Hypertension 1: 643–649, 1979
Weidmann P, Maxwell MH: The renin angiotensin aldosterone system in terminal renal failure. Kidney Int 8: 5: 219s–234s, 1975
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Martinus Nijhoff Publishers, Boston/The Hague/Dordrecht/Lancaster
About this chapter
Cite this chapter
Swales, J.D. (1984). Is there a Fault in the Renin-Angiotensin System in Essential Hypertension?. In: Sambhi, M.P. (eds) Fundamental Fault in Hypertension. Developments in Cardiovascular Medicine, vol 36. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-5678-0_23
Download citation
DOI: https://doi.org/10.1007/978-94-009-5678-0_23
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-9006-3
Online ISBN: 978-94-009-5678-0
eBook Packages: Springer Book Archive